In Vitro Digestion of Peanut Skin Releases Bioactive Compounds and Increases Cancer Cell Toxicity
-
Published:2023-06-28
Issue:7
Volume:12
Page:1356
-
ISSN:2076-3921
-
Container-title:Antioxidants
-
language:en
-
Short-container-title:Antioxidants
Author:
Cordeiro-Massironi Karina1, Soares-Freitas Rosana Aparecida M.1, Sampaio Geni Rodrigues1ORCID, Pinaffi-Langley Ana Clara da C.2ORCID, Bridi Raquel3ORCID, de Camargo Adriano Costa4ORCID, Torres Elizabeth Aparecida F. S.1ORCID
Affiliation:
1. Department of Nutrition, School of Public Health, University of São Paulo, São Paulo 01246-904, Brazil 2. Department of Nutrition Sciences, College of Allied Health, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73117, USA 3. Departamento de Química Farmacológica y Toxicológica, Facultad de Ciencias Químicas y Farmacéuticas, Universidad de Chile, Santiago 8380000, Chile 4. Nutrition and Food Technology Institute, University of Chile, Santiago 7830490, Chile
Abstract
Peanut skin is a rich source of bioactive compounds which may be able to reduce the risk factors associated with metabolic syndromes. This study aimed to characterize bio-compounds from peanut skin (Arachis hypogaea) and their bioactivity (antioxidant activity, inhibition of lipase, and carbohydrase enzymes) and to evaluate their anti-proliferative properties in colorectal cancer cells (HCT116) upon in vitro digestion. Peanut skin was digested in two sequential phases, and the final content, named phase-1 (P1) and phase-2 (P2) extracts, was evaluated. Several bioactive compounds were positively identified and quantified by liquid chromatography, including quinic acid, released especially after in vitro digestion. The total phenolic content and, regardless of the method, the antioxidant activity of P1 was higher than P2. P1 also showed a lower enzyme inhibitory concentration IC50 than P2, lipase, and α-glucosidase. For cell viability in HCT116 cells, lower concentrations of P1 were found for IC50 compared to P2. In conclusion, bioactive compounds were released mainly during the first phase of the in vitro digestion. The digested samples presented antioxidant activity, enzyme inhibitory activity, and cancer cell cytotoxicity, especially those from the P1 extract. The potential applications of such a by-product in human health are reported.
Funder
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior–Brazil
Subject
Cell Biology,Clinical Biochemistry,Molecular Biology,Biochemistry,Physiology
Reference80 articles.
1. Functional importance of bioactive compounds of foods with Potential Health Benefits: A review on recent trends;Banwo;Food Biosci.,2021 2. Relja, A., Miljković, A., Gelemanović, A., Bošković, M., Hayward, C., Polašek, O., and Kolčić, I. (2017). Nut Consumption and Cardiovascular Risk Factors: A Cross-Sectional Study in a Mediterranean Population. Nutrients, 9. 3. Effects of tree nuts on blood lipids, apolipoproteins, and blood pressure: Systematic review, meta-analysis, and dose-response of 61 controlled intervention trials;Falk;Am. J. Clin. Nutr.,2015 4. Viguiliouk, E., Kendall, C.W.C., Mejia, S.B., Cozma, A.I., Ha, V., Mirrahimi, A., Jayalath, V.H., Augustin, L.S.A., Chiavaroli, L., and Leiter, L.A. (2014). Effect of Tree Nuts on Glycemic Control in Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Dietary Trials. PLoS ONE, 9. 5. Vadalà, R., Di Bella, G., Kosakowska, O., Dugo, G., Cicero, N., and Costa, R. (2023). 2.20—Nutritional Benefits of Peanut By-Products. Sustain. Food Sci. -A Compr. Approach, 289–301.
|
|